World

Jailed Belarus Nobel winner should have been freed in prisoner swap

Aug 04, 2024

Minsk [Belarus], August 4: Supporters of jailed Belarusian Nobel Peace laureate Ales Bialiatski say the human rights activist should have been included in the biggest East-West prisoner swap since the Cold War.
Allies of Bialiatski and other jailed Belarusians are disappointed they were not included in the swap, which saw eight Russians, including a convicted murderer, exchanged for 16 prisoners in Russian and Belarusian jails, many of them dissidents.
Some of the Russian dissidents freed in the swap, including Ilya Yashin, an opposition activist, expressed anger or reservations on Friday at having been deported from their country against their will.
Bialiatski, 61, who is serving a 10-year sentence for financing anti-government protests after a trial in 2023 condemned by the U.S. and the European Union as a "sham", was awarded the Nobel Peace Prize in 2022 - a year after his arrest.
"When we heard that the deal is imminent, we hoped that someone from Belarus political prisoners will surely be a part of it. First of all, of course, the jailed Nobel Peace Prize winner," said Alena Masliukova, a member of Viasna - the human rights organisation founded by Bialiatski.
Source: Fijian Broadcasting Corporation

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025